Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Journal of Chemotherapy (Florence, Italy)|December 4, 2008
Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICEI Aurer, Z Mitrović, D Nemet, et al.
Bone Marrow Transplantation|April 1, 1991
Are new conditioning regimens for transplants in acute myelogenous leukemia better?I Aurer, R P Gale
Bone Marrow Transplantation|August 1, 1990
What is the role of recombinant colony stimulating factors in bone marrow transplantation?I Aurer, A Ribas, R P Gale
Blood|November 1, 1991
BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemiaI Aurer, A Butturini, R P Gale
Lijecnicki Vjesnik|September 1, 1990
[Hematopoietic growth factors]Z Pavletić, B Labar
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience)I Radman, N Basić, B Labar, et al.
Clinical Chemistry|December 1, 1988
Subtyping of erythrocyte phosphoglucomutase-1 as a genetic marker for bone-marrow engraftment and hematopoietic chimerism after allogeneic bone-marrow transplantation in a patient with acute lymphoblastic leukemiaB Grahovac, B Labar, A Stavijenić
Enzyme|January 1, 1988
Phenotyping of phosphoglucomutase (PGM1) isoenzymes--a new method for the follow-up of chimerism after bone marrow transplantation. Follow-up of chimerism after bone marrow transplantation by phenotyping of phosphoglucomutase (PGM1) isoenzymesB Grahovac, B Labar, A Stavljenic
Enzyme|January 1, 1984
Red cell pyruvate kinase in acute leukemiaB Labar, A Stavljenić, L Jusufhodzić
American Journal of Hematology|May 1, 1993
Ph1-chromosome positive acute lymphoblastic leukemia: is t(9;22) the initial abnormality?I Aurer, R S Sparkes, G Schiller, et al.
Pageof 8